sub:assertion {
  d:DB00123 v:identifier "DB00123" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB00123" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB00123> ;
    dv:drugbank-id "DB00123" , "NUTR00037" ;
    dv:x-atc <http://bio2rdf.org/atc:B05XB03> ;
    dv:x-cas <http://bio2rdf.org/cas:56-87-1> ;
    dv:x-chebi <http://bio2rdf.org/chebi:18019> ;
    dv:x-kegg <http://bio2rdf.org/kegg:C00047> , <http://bio2rdf.org/kegg:D02304> ;
    dv:x-pdb <http://bio2rdf.org/pdb:LYS> ;
    dv:x-pharmgkb <http://bio2rdf.org/pharmgkb:PA450280> ;
    dv:x-wikipedia <http://bio2rdf.org/wikipedia:L-Lysine> ;
    dct:description """L-Lysine (abbreviated as Lys or K) is an α-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. This amino acid is an essential amino acid, which means that humans cannot synthesize it. Its codons are AAA and AAG.

L-Lysine is a base, as are arginine and histidine. The ε-amino group often participates in hydrogen bonding and as a general base in catalysis. Common posttranslational modifications include methylation of the ε-amino group, giving methyl-, dimethyl-, and trimethyllysine. The latter occurs in calmodulin. Other posttranslational modifications include acetylation. Collagen contains hydroxylysine which is derived from lysine by lysyl hydroxylase. O-Glycosylation of lysine residues in the endoplasmic reticulum or Golgi apparatus is used to mark certain proteins for secretion from the cell."""@en ;
    dct:identifier "drugbank:DB00123" ;
    dct:title "L-Lysine"@en ;
    a dv:Drug ;
    rdfs:label "L-Lysine [drugbank:DB00123]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB00123> , <http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/lly_0166.shtml> .
}